Autres langues Karolinska Development AB

Actions

KDEV

SE0002190926

Marché Fermé - Nasdaq Stockholm Autres places de cotation 12:59:43 30/04/2024			Varia. 5j.	Varia. 1 janv.
1,566 ^SEK	-0,38 %		+3,98 %	-7,77 %

26/04	Karolinska Development AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
16/04	Karolinska Development AB (Publ) annonce que Bjorn Cochlovius a décliné sa réélection	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Interim Report - January-March 2024	26/04
Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Notice of Annual General Meeting in Karolinska Development AB (publ)	16/04
Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election	16/04
Karolinska Development : portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC	22/03
Karolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC	22/03
Karolinska Development Annual Report 2023 published	22/03
Karolinska Development Annual Report 2023 published	22/03
Karolinska Development : portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million	14/03
Karolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million	14/03
Karolinska Development : portfolio company Biosergen publishes prospectus due to rights issue of units	14/03
Karolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of units	14/03
Karolinska Development : portfolio company Umecrine Cognition presents preclinical Parkinson's data on golexanolone at AD/PD	06/03
Karolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PD	06/03
Year-end Report - January-December 2023	16/02
Karolinska Development AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Karolinska Development Portfolio Company AnaCardio Completes SEK150 Million Funding Round	17/01
Karolinska Development’s portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round	17/01
AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB	17/01
Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product	09/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Karolinska Development AB

Actions

KDEV

SE0002190926

Autres langues

Filtres